---
figid: PMC6756870__aging-11-102244-g006
figtitle: Proposed model
organisms:
- Homo sapiens
- Mus musculus
- Corynephage beta
pmcid: PMC6756870
filename: aging-11-102244-g006.jpg
figlink: /pmc/articles/PMC6756870/figure/f6/
number: F6
caption: Proposed model. Pictures showing that AZ628 and BP-1-102 combination inhibits
  RAS-mutant lung cancer cells by markedly abrogating MEK/ERK signaling pathway activation.
papertitle: STAT3 inhibitor sensitized KRAS-mutant lung cancers to RAF inhibitor by
  activating MEK/ERK signaling pathway.
reftext: Zhenlin Wang, et al. Aging (Albany NY). 2019 Sep 15;11(17):7187-7196.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9641388
figid_alias: PMC6756870__F6
figtype: Figure
organisms_ner:
- Mus musculus
redirect_from: /figures/PMC6756870__F6
ndex: 3d57cf42-ded0-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6756870__aging-11-102244-g006.html
  '@type': Dataset
  description: Proposed model. Pictures showing that AZ628 and BP-1-102 combination
    inhibits RAS-mutant lung cancer cells by markedly abrogating MEK/ERK signaling
    pathway activation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ras
  - Hras
  - Kras
  - Rem1
  - Zhx2
  - Map2k1
  - Map2k2
  - Mapk3
  - Mapk1
  - Stat3
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
---
